The Mid-South Miracle: A Program-Based Approach to Reducing Population-Level Lung Cancer Mortality
Dr. Osarogiagbon is the Chief Scientist at Baptist Memorial Healthcare Corporation, headquartered in Memphis, Tennessee. He is Director of the Multidisciplinary Thoracic Oncology Program and the Thoracic Oncology Research Group at the Baptist Cancer Center and Principal Investigator of the Baptist Health System/Mid-South Minority-Underserved Consortium NCORP. He is a Research Professor at Vanderbilt University and a member of the Vanderbilt Ingram Cancer Center.
Dr. Osarogiagbon’s research interests center around improving population-level outcomes of cancer care by improving care delivery systems and processes. His current major endeavor is the “Mid-South Miracle”: an institution-wide project to disseminate seven high-quality lung cancer control programs (including tobacco control, early detection and clinical trials infrastructure) across a 107-county, six-state service area population of the Baptist Memorial Healthcare Corporation with the goal of reducing population-level lung cancer mortality by 25% greater than the U.S. average over the course of a decade.
He is a member of the NCI Cancer Prevention Steering Committee, the International Association for the Study of Lung Cancer (IASLC) Staging and Prognostic Factors Committee, the Fleischner Society and the Alpha Omega Alpha Honor Medical Society. Dr. Osarogiagbon is board certified in the Internal Medicine subspecialties of Hematology and Medical Oncology, a Fellow of the American College of Physicians and member of American Society of Clinical Oncology and the American Society of Hematology.